Mother-to-child transmission of human immunodeficiency virus type 1.

PubWeight™: 1.08‹?› | Rank: Top 10%

🔗 View Article (PMC 3372415)

Published in Epidemiol Rev on January 01, 1996

Authors

G C John1, J Kreiss

Author Affiliations

1: Department of Medicine, University of Washington, Seattle 98195, USA.

Articles cited by this

Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med (1994) 25.02

Risk of human immunodeficiency virus type 1 transmission through breastfeeding. Lancet (1992) 7.56

Selective transmission of human immunodeficiency virus type-1 variants from mothers to infants. Science (1992) 7.44

Prognostic value of HIV-1 syncytium-inducing phenotype for rate of CD4+ cell depletion and progression to AIDS. Ann Intern Med (1993) 7.21

Identification of levels of maternal HIV-1 RNA associated with risk of perinatal transmission. Effect of maternal zidovudine treatment on viral load. JAMA (1996) 4.33

A prospective study of infants born to women seropositive for human immunodeficiency virus type 1. HIV Infection in Newborns French Collaborative Study Group. N Engl J Med (1989) 3.98

Clearance of HIV infection in a perinatally infected infant. N Engl J Med (1995) 3.76

Risk factors for mother-to-child transmission of HIV-1. Lancet (1992) 3.76

Independent introduction of two major HIV-1 genotypes into distinct high-risk populations in Thailand. Lancet (1993) 3.28

HIV-1 Langerhans' cell tropism associated with heterosexual transmission of HIV. Science (1996) 2.79

HIV-specific cytotoxic T-cell activity in an HIV-exposed but uninfected infant. Lancet (1993) 2.71

Perinatal transmission of the human immunodeficiency virus type 1 to infants of seropositive women in Zaire. N Engl J Med (1989) 2.68

High risk of HIV-1 infection for first-born twins. The International Registry of HIV-exposed Twins. Lancet (1991) 2.51

Comparison of variable region 3 sequences of human immunodeficiency virus type 1 from infected children with the RNA and DNA sequences of the virus populations of their mothers. Proc Natl Acad Sci U S A (1993) 2.49

Detection of HIV DNA in cervical and vaginal secretions. Prevalence and correlates among women in Nairobi, Kenya. JAMA (1993) 2.41

Maternal vitamin A deficiency and mother-to-child transmission of HIV-1. Lancet (1994) 2.38

Detection of virus in vertically exposed HIV-antibody-negative children. Lancet (1996) 2.38

Proposed definitions for in utero versus intrapartum transmission of HIV-1. N Engl J Med (1992) 2.33

Infective and anti-infective properties of breastmilk from HIV-1-infected women. Lancet (1993) 2.18

Mother-to-child transmission of HIV-1 in Congo, central Africa. Congolese Research Group on Mother-to-Child Transmission of HIV. AIDS (1994) 2.18

Factors predictive of maternal-fetal transmission of HIV-1. Preliminary analysis of zidovudine given during pregnancy and/or delivery. JAMA (1994) 2.14

Mother-to-infant transmission of human immunodeficiency virus type 1: association with prematurity or low anti-gp120. Lancet (1989) 2.12

Supplementation with vitamin A and iron for nutritional anaemia in pregnant women in West Java, Indonesia. Lancet (1993) 2.11

Genital shedding of human immunodeficiency virus type 1 DNA during pregnancy: association with immunosuppression, abnormal cervical or vaginal discharge, and severe vitamin A deficiency. J Infect Dis (1997) 2.02

Syncytium-inducing and non-syncytium-inducing capacity of human immunodeficiency virus type 1 subtypes other than B: phenotypic and genotypic characteristics. WHO Network for HIV Isolation and Characterization. AIDS Res Hum Retroviruses (1994) 1.99

Mother-to-child transmission of human immunodeficiency virus type 1: report from the Nairobi Study. J Infect Dis (1994) 1.94

Caesarean section and risk of vertical transmission of HIV-1 infection. The European Collaborative Study. Lancet (1994) 1.93

Virus excretion in the cervicovaginal secretions of pregnant and nonpregnant HIV-infected women. J Acquir Immune Defic Syndr (1993) 1.91

Cytotoxic T lymphocyte responses in the peripheral blood of children born to human immunodeficiency virus-1-infected mothers. Eur J Immunol (1992) 1.89

Mother-to-child transmission of human immunodeficiency virus type 1: correlation with neutralizing antibodies against primary isolates. J Infect Dis (1993) 1.86

Human immunodeficiency virus DNA in urethral secretions in men: association with gonococcal urethritis and CD4 cell depletion. J Infect Dis (1995) 1.86

Prospective comparison of mother-to-child transmission of HIV-1 and HIV-2 in Abidjan, Ivory Coast. JAMA (1994) 1.84

Estimated timing of mother-to-child human immunodeficiency virus type 1 (HIV-1) transmission by use of a Markov model. The HIV Infection in Newborns French Collaborative Study Group. Am J Epidemiol (1995) 1.84

Children born to women with HIV-1 infection: natural history and risk of transmission. European Collaborative Study. Lancet (1991) 1.75

Association between cervical inflammation and cervical shedding of human immunodeficiency virus DNA. J Infect Dis (1994) 1.70

Rates of mother-to-child transmission of HIV-1 in Africa, America, and Europe: results from 13 perinatal studies. The Working Group on Mother-To-Child Transmission of HIV. J Acquir Immune Defic Syndr Hum Retrovirol (1995) 1.67

Human immunodeficiency virus type 1-infected cells in breast milk: association with immunosuppression and vitamin A deficiency. J Infect Dis (1995) 1.62

Perinatal intervention trial in Africa: effect of a birth canal cleansing intervention to prevent HIV transmission. Lancet (1996) 1.62

HIV-1 subtypes and male-to-female transmission in Thailand. Lancet (1995) 1.59

Maternal IgG1 and IgA antibody to V3 loop consensus sequence and maternal-infant HIV-1 transmission. Lancet (1994) 1.50

Perinatal transmission of HIV-I in Zambia. BMJ (1989) 1.41

Persistence of multiple maternal genotypes of human immunodeficiency virus type I in infants infected by vertical transmission. J Clin Invest (1994) 1.41

Biological properties of HIV isolates in primary HIV infection: consequences for the subsequent course of infection. AIDS (1993) 1.36

Similarity in env and gag genes between genomic RNAs of human immunodeficiency virus type 1 (HIV-1) from mother and infant is unrelated to time of HIV-1 RNA positivity in the child. J Virol (1995) 1.33

Risk for perinatal HIV-1 transmission according to maternal immunologic, virologic, and placental factors. JAMA (1993) 1.28

The effects of vitamin A supplementation on the morbidity of children born to HIV-infected women. Am J Public Health (1995) 1.24

Maternal predictors of perinatal human immunodeficiency virus transmission. The New York City Perinatal HIV Transmission Collaborative Study Group. Pediatr Infect Dis J (1994) 1.24

Prevalence of HIV-1 DNA and p24 antigen in breast milk and correlation with maternal factors. J Acquir Immune Defic Syndr (1994) 1.24

A hospital-based prospective study of perinatal infection with human immunodeficiency virus type 1. J Pediatr (1991) 1.23

The duration of breastfeeding by HIV-1-infected mothers in developing countries: balancing benefits and risks. J Acquir Immune Defic Syndr Hum Retrovirol (1995) 1.18

Analysis of envelope sequence variants suggests multiple mechanisms of mother-to-child transmission of human immunodeficiency virus type 1. J Virol (1995) 1.12

Cellular immune factors associated with mother-to-infant transmission of HIV. AIDS (1993) 1.11

Heteroduplex mobility assay and phylogenetic analysis of V3 region sequences of human immunodeficiency virus type 1 isolates from Gulu, northern Uganda. The Italian-Ugandan Cooperation AIDS Program. J Virol (1995) 1.10

Viral phenotype and host-cell susceptibility to HIV-1 infection as risk factors for mother-to-child HIV-1 transmission. AIDS (1995) 1.09

Maternal factors associated with perinatal HIV-1 transmission: the French Cohort Study: 7 years of follow-up observation. The French Pediatric HIV Infection Study Group. J Acquir Immune Defic Syndr Hum Retrovirol (1995) 1.06

Maternal and neonatal characteristics associated with HIV infection in infants of seropositive women. J Acquir Immune Defic Syndr (1993) 1.01

Maternal antibodies to gp120 V3 sequence do not correlate with protection against vertical transmission of human immunodeficiency virus. J Infect Dis (1992) 1.00

The relationship of the duration of ruptured membranes to vertical transmission of human immunodeficiency virus. Am J Obstet Gynecol (1995) 0.99

Frequency of early in utero HIV-1 infection: a blind DNA polymerase chain reaction study on 100 fetal thymuses. AIDS (1995) 0.97

Vertical Transmission of HIV-1. Correlation with maternal viral load and plasma levels of CD4 binding site anti-gp120 antibodies. J Clin Invest (1995) 0.96

Human cord blood mononuclear cells are preferentially infected by non-syncytium-inducing, macrophage-tropic human immunodeficiency virus type 1 isolates. J Clin Microbiol (1995) 0.94

Vertical transmission of human immunodeficiency virus type 1: autologous neutralizing antibody, virus load, and virus phenotype. J Pediatr (1995) 0.94

Mother-to-child transmission of human immunodeficiency virus type 1: risk of infection and correlates of transmission. Pediatrics (1992) 0.92

Birth order, delivery route, and concordance in the transmission of human immunodeficiency virus type 1 from mothers to twins. International Registry of HIV-Exposed Twins. J Pediatr (1995) 0.90

Human immunodeficiency virus isolated from amniotic fluid. Lancet (1987) 0.90

Association between anti-human immunodeficiency virus type 1 (HIV-1) antibody-dependent cellular cytotoxicity antibody titers at birth and vertical transmission of HIV-1. J Infect Dis (1994) 0.89

Transmission of HIV-1 infections from mothers to infants in Haiti. Impact on childhood mortality and malnutrition. The CDS/JHU AIDS Project Team. JAMA (1990) 0.88

Mother-to-child transmission of human immunodeficiency virus type 1 (HIV-1) and its determinants: a cohort study in Kigali, Rwanda. Am J Epidemiol (1993) 0.88

Mother-to-child transmission of human immunodeficiency virus type 1: influence of parity and mode of delivery. Paediatric AIDS Group of Switzerland. Eur J Pediatr (1995) 0.88

Detection of human immunodeficiency virus type 1 (HIV-1) proviral DNA in breast milk and colostrum of seropositive mothers. J Med Assoc Thai (1993) 0.88

Multiple sexual partners and mother-to-child transmission of HIV-1. AIDS (1993) 0.87

An assessment of the timing of mother-to-child transmission of human immunodeficiency virus type 1 by means of polymerase chain reaction. J Acquir Immune Defic Syndr (1994) 0.86

Maternal antibody response at delivery and perinatal transmission of human immunodeficiency virus type 1 in African women. Lancet (1994) 0.86

Postnatal transmission of HIV-1 associated with breast abscess. Lancet (1992) 0.85

Risk factors for mother-to-child transmission of human immunodeficiency virus-1 infection. Am J Obstet Gynecol (1995) 0.85

Beta 2-microglobulin, HIV-1 p24 antibody and acid-dissociated HIV-1 p24 antigen levels: predictive markers for vertical transmission of HIV-1 in pregnant Ugandan women. AIDS (1993) 0.84

Comparison of vertical human immunodeficiency virus type 2 and human immunodeficiency virus type 1 transmission in the French prospective cohort. The HIV Infection in Newborns French Collaborative Study Group. Pediatr Infect Dis J (1994) 0.83

The epidemiology of HIV infection in children and their mothers--vertical transmission. Epidemiol Rev (1991) 0.82

Human immunodeficiency virus type 1 infection and breast milk. The Italian Register for HIV Infection in Children. Acta Paediatr Suppl (1994) 0.80

A critical review of studies evaluating the relationship of mode of delivery to perinatal transmission of human immunodeficiency virus. Pediatr Infect Dis J (1995) 0.79

Comparison of methods of estimating the mother-to-child transmission rate of human immunodeficiency virus type 1 (HIV-1). New York City Perinatal HIV Transmission Collaborative Study Group. Am J Epidemiol (1995) 0.78

Immunoglobulin class and subclass antibodies to HIV proteins in maternal serum: association with perinatal transmission. J Acquir Immune Defic Syndr (1994) 0.78

Cesarean section to reduce perinatal transmission of human immunodeficiency virus. A metaanalysis. Online J Curr Clin Trials (1993) 0.77

A prospective population-based study of HIV perinatal transmission. AIDS (1994) 0.77

Quantitative analysis of human immunodeficiency virus type 1 antibody reactivity by western immunoblots: evaluation of relative antibody levels in seropositive individuals and mothers. J Infect Dis (1992) 0.76

A prospective study of mother-to-infant HIV transmission in tribal women from India. J Acquir Immune Defic Syndr Hum Retrovirol (1995) 0.76

Predictive markers for mother-to-child transmission of HIV-1 in Dar es Salaam, Tanzania. J Acquir Immune Defic Syndr Hum Retrovirol (1995) 0.76

Articles by these authors

Effect of breastfeeding and formula feeding on transmission of HIV-1: a randomized clinical trial. JAMA (2000) 10.40

Vaginal lactobacilli, microbial flora, and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition. J Infect Dis (1999) 6.85

Morbidity and mortality in breastfed and formula-fed infants of HIV-1-infected women: A randomized clinical trial. JAMA (2001) 5.77

Effect of breastfeeding on mortality among HIV-1 infected women: a randomised trial. Lancet (2001) 5.10

Rapid method for screening dried blood samples on filter paper for human immunodeficiency virus type 1 DNA. J Clin Microbiol (1999) 3.88

Hormonal contraception, sexually transmitted diseases, and risk of heterosexual transmission of human immunodeficiency virus type 1. J Infect Dis (1998) 2.96

Human immunodeficiency virus infection in long-distance truck drivers in east Africa. Arch Intern Med (1994) 2.01

The increasing frequency of heterosexually acquired AIDS in the United States, 1983-88. Am J Public Health (1990) 1.99

Role of sexually transmitted diseases in transmitting human immunodeficiency virus. Genitourin Med (1988) 1.78

Primary human immunodeficiency virus type 1 infection: clinical manifestations among women in Mombasa, Kenya. Clin Infect Dis (2000) 1.56

Comparison of techniques for HIV-1 RNA detection and quantitation in cervicovaginal secretions. J Acquir Immune Defic Syndr (2001) 1.41

Cofactors for the acquisition of HIV-1 among heterosexual men: prospective cohort study of trucking company workers in Kenya. AIDS (1999) 1.27

Viral envelope protein of HTLV-III is the major target antigen for antibodies in hemophiliac patients. J Infect Dis (1986) 1.20

Characteristics of drug resistance and HIV among tuberculosis patients in Mozambique. Int J Tuberc Lung Dis (2001) 1.17

Effect of human immunodeficiency virus type 1 infection upon acute salpingitis: a laparoscopic study. J Infect Dis (1998) 1.15

Human T cell lymphotropic virus type I infection among female sex workers in Peru. J Infect Dis (1994) 1.02

Heterosexual transmission of human immunodeficiency virus: overview of a neglected aspect of the AIDS epidemic. J Acquir Immune Defic Syndr (1988) 1.00

Effects of human immunodeficiency virus 1 infection on microbial origins of pelvic inflammatory disease and on efficacy of ambulatory oral therapy. Am J Obstet Gynecol (1999) 1.00

Studies of human immunodeficiency virus type 1 mucosal viral shedding and transmission in Kenya. J Infect Dis (1999) 0.95

Human immunodeficiency virus infection among high-risk seronegative prostitutes in Nairobi. J Infect Dis (1993) 0.92

Long distance truck-drivers: 1. Prevalence of sexually transmitted diseases (STDs). East Afr Med J (1991) 0.92

Rapid and inexpensive approaches to managing abnormal vaginal discharge or lower abdominal pain: an evaluation in women attending gynaecology and family planning clinics in Peru. Sex Transm Infect (1998) 0.87

Antibodies to human T-cell leukemia virus membrane antigens (HTLV-MA) in hemophiliacs. Science (1983) 0.85

Postnatal transmission of HIV-1 through pooled breast milk. Lancet (1994) 0.83

The Nairobi STD program. An international partnership. Infect Dis Clin North Am (1991) 0.83

Syphilis and HIV infection among prisoners in Maputo, Mozambique. Int J STD AIDS (1995) 0.83

Role of GDP in formyl-peptide-receptor-induced activation of guanine-nucleotide-binding proteins in membranes of HL 60 cells. Eur J Biochem (1992) 0.79

Beta-2 microglobulin as a marker of HIV disease status in Nairobi, Kenya. Int J STD AIDS (1993) 0.75

The challenge of limiting the spread of human immunodeficiency virus by controlling other sexually transmitted diseases. Arch Dermatol (1991) 0.75